Search research articles
Contact Us
Filters
Showing results (131-140 of 247) with videos related to
Page
of 25
Sort By:
British Journal of Rheumatology
|
August 1, 1994
Expression of complement regulatory molecules and other surface markers on neutrophils from synovial fluid and blood of patients with rheumatoid arthritis
J Jones, I Laffafian, A M Cooper, et al.
Clinical and Experimental Immunology
|
August 10, 2000
Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack
O B Spiller, O Criado-García, S Rodríguez De Córdoba, et al.
Journal of Neuroimmunology
|
December 1, 1996
Soluble complement receptor 1 (sCR1) protects against experimental autoimmune myasthenia gravis
S J Piddlesden, S Jiang, J L Levin, et al.
Clinical and Experimental Immunology
|
October 13, 2006
Complement membrane attack is required for endplate damage and clinical disease in passive experimental myasthenia gravis in Lewis rats
J Chamberlain-Banoub, J W Neal, M Mizuno, et al.
The Journal of Biological Chemistry
|
April 10, 1999
Identification of the individual residues that determine human CD59 species selective activity
H F Zhang, J Yu, S Chen, et al.
Journal of Neuroimmunology
|
December 1, 1996
Complement expression on astrocytes and astrocytoma cell lines: failure of complement regulation at the C3 level correlates with very low CD55 expression
O B Spiller, G Moretto, S U Kim, et al.
Immunology
|
November 21, 1998
Characterization in vitro and in vivo of the pig analogue of human CD59 using new monoclonal antibodies
S M Hanna, G T Williams, C W Van Den Berg, et al.
Biochimica Et Biophysica Acta
|
February 14, 1987
The inhibition of phospholipase A2 by manoalide and manoalide analogues
R A Deems, D Lombardo, B P Morgan, et al.
Clinical and Experimental Immunology
|
March 1, 1989
A case of hereditary combined deficiency of complement components C6 and C7 in man
B P Morgan, J P Vora, A J Bennett, et al.
Clinical and Experimental Immunology
|
February 5, 1999
Protection of human breast cancer cells from complement-mediated lysis by expression of heterologous CD59
J Yu, T Caragine, S Chen, et al.
Page
of 25
Search research articles
Search
Showing results (131-140 of 247) with videos related to
Sort By:
Page
of 25
British Journal of Rheumatology
|
August 1, 1994
Expression of complement regulatory molecules and other surface markers on neutrophils from synovial fluid and blood of patients with rheumatoid arthritis
J Jones, I Laffafian, A M Cooper, et al.
Clinical and Experimental Immunology
|
August 10, 2000
Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack
O B Spiller, O Criado-García, S Rodríguez De Córdoba, et al.
Journal of Neuroimmunology
|
December 1, 1996
Soluble complement receptor 1 (sCR1) protects against experimental autoimmune myasthenia gravis
S J Piddlesden, S Jiang, J L Levin, et al.
Clinical and Experimental Immunology
|
October 13, 2006
Complement membrane attack is required for endplate damage and clinical disease in passive experimental myasthenia gravis in Lewis rats
J Chamberlain-Banoub, J W Neal, M Mizuno, et al.
The Journal of Biological Chemistry
|
April 10, 1999
Identification of the individual residues that determine human CD59 species selective activity
H F Zhang, J Yu, S Chen, et al.
Journal of Neuroimmunology
|
December 1, 1996
Complement expression on astrocytes and astrocytoma cell lines: failure of complement regulation at the C3 level correlates with very low CD55 expression
O B Spiller, G Moretto, S U Kim, et al.
Immunology
|
November 21, 1998
Characterization in vitro and in vivo of the pig analogue of human CD59 using new monoclonal antibodies
S M Hanna, G T Williams, C W Van Den Berg, et al.
Biochimica Et Biophysica Acta
|
February 14, 1987
The inhibition of phospholipase A2 by manoalide and manoalide analogues
R A Deems, D Lombardo, B P Morgan, et al.
Clinical and Experimental Immunology
|
March 1, 1989
A case of hereditary combined deficiency of complement components C6 and C7 in man
B P Morgan, J P Vora, A J Bennett, et al.
Clinical and Experimental Immunology
|
February 5, 1999
Protection of human breast cancer cells from complement-mediated lysis by expression of heterologous CD59
J Yu, T Caragine, S Chen, et al.
Page
of 25